*January 2022*
Highlights
- Clonal architecture of molecular alterations at the cellular level depicts cancer cell adaptation during targeted therapy.
- Single cell sequencing from patient biopsies revealed the co-existence of two driver alterations within single cancer cells.
- Pharmacological evaluation in patient derived models asserts the need of simultaneous inhibition of each driver.
